Pharma & Healthcare
Anti-Obesity Drugs (Anti-obesity Medication) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 552949
- Pages: 166
- Figures: 283
- Views: 1
Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. These medications alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories.
The global market for Anti-Obesity Drugs (Anti-obesity Medication) was estimated to be worth US$ 1824.1 million in 2023 and is forecast to a readjusted size of US$ 5569.5 million by 2030 with a CAGR of 17.0% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-Obesity Drugs (Anti-obesity Medication), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-Obesity Drugs (Anti-obesity Medication) by region & country, by Type, and by Application.
The Anti-Obesity Drugs (Anti-obesity Medication) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Obesity Drugs (Anti-obesity Medication).
Market Segmentation
By Company
Zafgan
Vivus
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
GlaxoSmithKline
F.Hoffmann-La Roche
Eisai
Boehringer Ingelheim
Bayer AG
AstraZeneca
Arena Pharmaceuticals
Amylin
Alizyme
Segment by Type:
by Drug Varieties
Prescription Drugs
OTC Drugs
by Acting
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Segment by Application
Childhood (0-6)
Juvenile (7-17)
Youth (18-40)
Middle Aged (41-60)
Elderly (Above 60)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anti-Obesity Drugs (Anti-obesity Medication) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anti-Obesity Drugs (Anti-obesity Medication) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anti-Obesity Drugs (Anti-obesity Medication) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Anti-Obesity Drugs (Anti-obesity Medication) was estimated to be worth US$ 1824.1 million in 2023 and is forecast to a readjusted size of US$ 5569.5 million by 2030 with a CAGR of 17.0% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-Obesity Drugs (Anti-obesity Medication), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-Obesity Drugs (Anti-obesity Medication) by region & country, by Type, and by Application.
The Anti-Obesity Drugs (Anti-obesity Medication) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Obesity Drugs (Anti-obesity Medication).
Market Segmentation
By Company
Zafgan
Vivus
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
GlaxoSmithKline
F.Hoffmann-La Roche
Eisai
Boehringer Ingelheim
Bayer AG
AstraZeneca
Arena Pharmaceuticals
Amylin
Alizyme
Segment by Type:
by Drug Varieties
Prescription Drugs
OTC Drugs
by Acting
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Segment by Application
Childhood (0-6)
Juvenile (7-17)
Youth (18-40)
Middle Aged (41-60)
Elderly (Above 60)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anti-Obesity Drugs (Anti-obesity Medication) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anti-Obesity Drugs (Anti-obesity Medication) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anti-Obesity Drugs (Anti-obesity Medication) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Anti-Obesity Drugs (Anti-obesity Medication) Product Introduction
1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast
1.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030)
1.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (2019-2030)
1.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Price (2019-2030)
1.3 Anti-Obesity Drugs (Anti-obesity Medication) Market Trends & Drivers
1.3.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Trends
1.3.2 Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers & Opportunity
1.3.3 Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
1.3.4 Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Players Revenue Ranking (2023)
2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2019-2024)
2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Players Sales Volume Ranking (2023)
2.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Company Players (2019-2024)
2.5 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Company (2019-2024)
2.6 Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Anti-Obesity Drugs (Anti-obesity Medication)
2.9 Anti-Obesity Drugs (Anti-obesity Medication) Market Competitive Analysis
2.9.1 Anti-Obesity Drugs (Anti-obesity Medication) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Prescription Drugs
3.1.2 OTC Drugs
3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type
3.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, by Type (2019-2030)
3.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, by Type (%) (2019-2030)
3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Type
3.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, by Type (2019-2030)
3.3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, by Type (%) (2019-2030)
3.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Childhood (0-6)
4.1.2 Juvenile (7-17)
4.1.3 Youth (18-40)
4.1.4 Middle Aged (41-60)
4.1.5 Elderly (Above 60)
4.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application
4.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, by Application (2019-2030)
4.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, by Application (%) (2019-2030)
4.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Application
4.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, by Application (2019-2030)
4.3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, by Application (%) (2019-2030)
4.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region
5.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (2019-2024)
5.1.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (2025-2030)
5.1.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (%), (2019-2030)
5.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region
5.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (2019-2024)
5.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (2025-2030)
5.2.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (%), (2019-2030)
5.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
5.4.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
5.5.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
5.6.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
5.7.2 South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
5.8.2 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value
6.2.1 Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.3.2 United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.4.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.5.2 China Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.6.2 Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.7.2 South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.8.2 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.9.2 India Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zafgan
7.1.1 Zafgan Company Information
7.1.2 Zafgan Introduction and Business Overview
7.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.1.5 Zafgan Recent Development
7.2 Vivus
7.2.1 Vivus Company Information
7.2.2 Vivus Introduction and Business Overview
7.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.2.5 Vivus Recent Development
7.3 Shionogi
7.3.1 Shionogi Company Information
7.3.2 Shionogi Introduction and Business Overview
7.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.3.5 Shionogi Recent Development
7.4 Sanofi
7.4.1 Sanofi Company Information
7.4.2 Sanofi Introduction and Business Overview
7.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.4.5 Sanofi Recent Development
7.5 Rhythm Pharmaceuticals
7.5.1 Rhythm Pharmaceuticals Company Information
7.5.2 Rhythm Pharmaceuticals Introduction and Business Overview
7.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.5.5 Rhythm Pharmaceuticals Recent Development
7.6 Pfizer
7.6.1 Pfizer Company Information
7.6.2 Pfizer Introduction and Business Overview
7.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.6.5 Pfizer Recent Development
7.7 Orexigen Therapeutics
7.7.1 Orexigen Therapeutics Company Information
7.7.2 Orexigen Therapeutics Introduction and Business Overview
7.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.7.5 Orexigen Therapeutics Recent Development
7.8 Novo Nordisk
7.8.1 Novo Nordisk Company Information
7.8.2 Novo Nordisk Introduction and Business Overview
7.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.8.5 Novo Nordisk Recent Development
7.9 Norgine
7.9.1 Norgine Company Information
7.9.2 Norgine Introduction and Business Overview
7.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.9.5 Norgine Recent Development
7.10 Nalpropion Pharmaceuticals Inc.
7.10.1 Nalpropion Pharmaceuticals Inc. Company Information
7.10.2 Nalpropion Pharmaceuticals Inc. Introduction and Business Overview
7.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.10.5 Nalpropion Pharmaceuticals Inc. Recent Development
7.11 Merck
7.11.1 Merck Company Information
7.11.2 Merck Introduction and Business Overview
7.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.11.5 Merck Recent Development
7.12 GlaxoSmithKline
7.12.1 GlaxoSmithKline Company Information
7.12.2 GlaxoSmithKline Introduction and Business Overview
7.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.12.4 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.12.5 GlaxoSmithKline Recent Development
7.13 F.Hoffmann-La Roche
7.13.1 F.Hoffmann-La Roche Company Information
7.13.2 F.Hoffmann-La Roche Introduction and Business Overview
7.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.13.4 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.13.5 F.Hoffmann-La Roche Recent Development
7.14 Eisai
7.14.1 Eisai Company Information
7.14.2 Eisai Introduction and Business Overview
7.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.14.5 Eisai Recent Development
7.15 Boehringer Ingelheim
7.15.1 Boehringer Ingelheim Company Information
7.15.2 Boehringer Ingelheim Introduction and Business Overview
7.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.15.5 Boehringer Ingelheim Recent Development
7.16 Bayer AG
7.16.1 Bayer AG Company Information
7.16.2 Bayer AG Introduction and Business Overview
7.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.16.5 Bayer AG Recent Development
7.17 AstraZeneca
7.17.1 AstraZeneca Company Information
7.17.2 AstraZeneca Introduction and Business Overview
7.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.17.4 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.17.5 AstraZeneca Recent Development
7.18 Arena Pharmaceuticals
7.18.1 Arena Pharmaceuticals Company Information
7.18.2 Arena Pharmaceuticals Introduction and Business Overview
7.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.18.5 Arena Pharmaceuticals Recent Development
7.19 Amylin
7.19.1 Amylin Company Information
7.19.2 Amylin Introduction and Business Overview
7.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.19.5 Amylin Recent Development
7.20 Alizyme
7.20.1 Alizyme Company Information
7.20.2 Alizyme Introduction and Business Overview
7.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.20.5 Alizyme Recent Development
8 Industry Chain Analysis
8.1 Anti-Obesity Drugs (Anti-obesity Medication) Industrial Chain
8.2 Anti-Obesity Drugs (Anti-obesity Medication) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Anti-Obesity Drugs (Anti-obesity Medication) Sales Model
8.5.2 Sales Channel
8.5.3 Anti-Obesity Drugs (Anti-obesity Medication) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Anti-Obesity Drugs (Anti-obesity Medication) Product Introduction
1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast
1.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030)
1.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (2019-2030)
1.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Price (2019-2030)
1.3 Anti-Obesity Drugs (Anti-obesity Medication) Market Trends & Drivers
1.3.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Trends
1.3.2 Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers & Opportunity
1.3.3 Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
1.3.4 Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Players Revenue Ranking (2023)
2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2019-2024)
2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Players Sales Volume Ranking (2023)
2.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Company Players (2019-2024)
2.5 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Company (2019-2024)
2.6 Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Anti-Obesity Drugs (Anti-obesity Medication)
2.9 Anti-Obesity Drugs (Anti-obesity Medication) Market Competitive Analysis
2.9.1 Anti-Obesity Drugs (Anti-obesity Medication) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Prescription Drugs
3.1.2 OTC Drugs
3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type
3.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, by Type (2019-2030)
3.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, by Type (%) (2019-2030)
3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Type
3.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, by Type (2019-2030)
3.3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, by Type (%) (2019-2030)
3.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Childhood (0-6)
4.1.2 Juvenile (7-17)
4.1.3 Youth (18-40)
4.1.4 Middle Aged (41-60)
4.1.5 Elderly (Above 60)
4.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application
4.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, by Application (2019-2030)
4.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, by Application (%) (2019-2030)
4.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Application
4.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, by Application (2019-2030)
4.3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, by Application (%) (2019-2030)
4.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region
5.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (2019-2024)
5.1.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (2025-2030)
5.1.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (%), (2019-2030)
5.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region
5.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (2019-2024)
5.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (2025-2030)
5.2.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (%), (2019-2030)
5.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
5.4.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
5.5.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
5.6.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
5.7.2 South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
5.8.2 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value
6.2.1 Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.3.2 United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.4.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.5.2 China Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.6.2 Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.7.2 South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.8.2 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019-2030
6.9.2 India Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zafgan
7.1.1 Zafgan Company Information
7.1.2 Zafgan Introduction and Business Overview
7.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.1.5 Zafgan Recent Development
7.2 Vivus
7.2.1 Vivus Company Information
7.2.2 Vivus Introduction and Business Overview
7.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.2.5 Vivus Recent Development
7.3 Shionogi
7.3.1 Shionogi Company Information
7.3.2 Shionogi Introduction and Business Overview
7.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.3.5 Shionogi Recent Development
7.4 Sanofi
7.4.1 Sanofi Company Information
7.4.2 Sanofi Introduction and Business Overview
7.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.4.5 Sanofi Recent Development
7.5 Rhythm Pharmaceuticals
7.5.1 Rhythm Pharmaceuticals Company Information
7.5.2 Rhythm Pharmaceuticals Introduction and Business Overview
7.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.5.5 Rhythm Pharmaceuticals Recent Development
7.6 Pfizer
7.6.1 Pfizer Company Information
7.6.2 Pfizer Introduction and Business Overview
7.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.6.5 Pfizer Recent Development
7.7 Orexigen Therapeutics
7.7.1 Orexigen Therapeutics Company Information
7.7.2 Orexigen Therapeutics Introduction and Business Overview
7.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.7.5 Orexigen Therapeutics Recent Development
7.8 Novo Nordisk
7.8.1 Novo Nordisk Company Information
7.8.2 Novo Nordisk Introduction and Business Overview
7.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.8.5 Novo Nordisk Recent Development
7.9 Norgine
7.9.1 Norgine Company Information
7.9.2 Norgine Introduction and Business Overview
7.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.9.5 Norgine Recent Development
7.10 Nalpropion Pharmaceuticals Inc.
7.10.1 Nalpropion Pharmaceuticals Inc. Company Information
7.10.2 Nalpropion Pharmaceuticals Inc. Introduction and Business Overview
7.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.10.5 Nalpropion Pharmaceuticals Inc. Recent Development
7.11 Merck
7.11.1 Merck Company Information
7.11.2 Merck Introduction and Business Overview
7.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.11.5 Merck Recent Development
7.12 GlaxoSmithKline
7.12.1 GlaxoSmithKline Company Information
7.12.2 GlaxoSmithKline Introduction and Business Overview
7.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.12.4 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.12.5 GlaxoSmithKline Recent Development
7.13 F.Hoffmann-La Roche
7.13.1 F.Hoffmann-La Roche Company Information
7.13.2 F.Hoffmann-La Roche Introduction and Business Overview
7.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.13.4 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.13.5 F.Hoffmann-La Roche Recent Development
7.14 Eisai
7.14.1 Eisai Company Information
7.14.2 Eisai Introduction and Business Overview
7.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.14.5 Eisai Recent Development
7.15 Boehringer Ingelheim
7.15.1 Boehringer Ingelheim Company Information
7.15.2 Boehringer Ingelheim Introduction and Business Overview
7.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.15.5 Boehringer Ingelheim Recent Development
7.16 Bayer AG
7.16.1 Bayer AG Company Information
7.16.2 Bayer AG Introduction and Business Overview
7.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.16.5 Bayer AG Recent Development
7.17 AstraZeneca
7.17.1 AstraZeneca Company Information
7.17.2 AstraZeneca Introduction and Business Overview
7.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.17.4 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.17.5 AstraZeneca Recent Development
7.18 Arena Pharmaceuticals
7.18.1 Arena Pharmaceuticals Company Information
7.18.2 Arena Pharmaceuticals Introduction and Business Overview
7.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.18.5 Arena Pharmaceuticals Recent Development
7.19 Amylin
7.19.1 Amylin Company Information
7.19.2 Amylin Introduction and Business Overview
7.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.19.5 Amylin Recent Development
7.20 Alizyme
7.20.1 Alizyme Company Information
7.20.2 Alizyme Introduction and Business Overview
7.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
7.20.5 Alizyme Recent Development
8 Industry Chain Analysis
8.1 Anti-Obesity Drugs (Anti-obesity Medication) Industrial Chain
8.2 Anti-Obesity Drugs (Anti-obesity Medication) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Anti-Obesity Drugs (Anti-obesity Medication) Sales Model
8.5.2 Sales Channel
8.5.3 Anti-Obesity Drugs (Anti-obesity Medication) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Anti-Obesity Drugs (Anti-obesity Medication) Market Trends
Table 2. Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers & Opportunity
Table 3. Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
Table 4. Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
Table 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2019-2024)
Table 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Anti-Obesity Drugs (Anti-obesity Medication) Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Anti-Obesity Drugs (Anti-obesity Medication)
Table 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (2019-2024) & (%)
Table 44. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (2025-2030) & (%)
Table 45. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (2019-2024) & (%)
Table 49. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (2025-2030) & (%)
Table 50. Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, (2025-2030) & (K Units)
Table 57. Zafgan Company Information
Table 58. Zafgan Introduction and Business Overview
Table 59. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 61. Zafgan Recent Development
Table 62. Vivus Company Information
Table 63. Vivus Introduction and Business Overview
Table 64. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 66. Vivus Recent Development
Table 67. Shionogi Company Information
Table 68. Shionogi Introduction and Business Overview
Table 69. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 71. Shionogi Recent Development
Table 72. Sanofi Company Information
Table 73. Sanofi Introduction and Business Overview
Table 74. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 76. Sanofi Recent Development
Table 77. Rhythm Pharmaceuticals Company Information
Table 78. Rhythm Pharmaceuticals Introduction and Business Overview
Table 79. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 81. Rhythm Pharmaceuticals Recent Development
Table 82. Pfizer Company Information
Table 83. Pfizer Introduction and Business Overview
Table 84. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 86. Pfizer Recent Development
Table 87. Orexigen Therapeutics Company Information
Table 88. Orexigen Therapeutics Introduction and Business Overview
Table 89. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 91. Orexigen Therapeutics Recent Development
Table 92. Novo Nordisk Company Information
Table 93. Novo Nordisk Introduction and Business Overview
Table 94. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 96. Novo Nordisk Recent Development
Table 97. Norgine Company Information
Table 98. Norgine Introduction and Business Overview
Table 99. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 101. Norgine Recent Development
Table 102. Nalpropion Pharmaceuticals Inc. Company Information
Table 103. Nalpropion Pharmaceuticals Inc. Introduction and Business Overview
Table 104. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 106. Nalpropion Pharmaceuticals Inc. Recent Development
Table 107. Merck Company Information
Table 108. Merck Introduction and Business Overview
Table 109. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 111. Merck Recent Development
Table 112. GlaxoSmithKline Company Information
Table 113. GlaxoSmithKline Introduction and Business Overview
Table 114. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 116. GlaxoSmithKline Recent Development
Table 117. F.Hoffmann-La Roche Company Information
Table 118. F.Hoffmann-La Roche Introduction and Business Overview
Table 119. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 121. F.Hoffmann-La Roche Recent Development
Table 122. Eisai Company Information
Table 123. Eisai Introduction and Business Overview
Table 124. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 126. Eisai Recent Development
Table 127. Boehringer Ingelheim Company Information
Table 128. Boehringer Ingelheim Introduction and Business Overview
Table 129. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 131. Boehringer Ingelheim Recent Development
Table 132. Bayer AG Company Information
Table 133. Bayer AG Introduction and Business Overview
Table 134. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 136. Bayer AG Recent Development
Table 137. AstraZeneca Company Information
Table 138. AstraZeneca Introduction and Business Overview
Table 139. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 141. AstraZeneca Recent Development
Table 142. Arena Pharmaceuticals Company Information
Table 143. Arena Pharmaceuticals Introduction and Business Overview
Table 144. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 146. Arena Pharmaceuticals Recent Development
Table 147. Amylin Company Information
Table 148. Amylin Introduction and Business Overview
Table 149. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 150. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 151. Amylin Recent Development
Table 152. Alizyme Company Information
Table 153. Alizyme Introduction and Business Overview
Table 154. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 155. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 156. Alizyme Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Anti-Obesity Drugs (Anti-obesity Medication) Downstream Customers
Table 160. Anti-Obesity Drugs (Anti-obesity Medication) Distributors List
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Obesity Drugs (Anti-obesity Medication) Product Picture
Figure 2. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (2019-2030) & (K Units)
Figure 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Price (2019-2030) & (USD/Unit)
Figure 6. Anti-Obesity Drugs (Anti-obesity Medication) Report Years Considered
Figure 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Anti-Obesity Drugs (Anti-obesity Medication) Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2023
Figure 10. Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Prescription Drugs Picture
Figure 12. OTC Drugs Picture
Figure 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2019-2030) & (USD/Unit)
Figure 18. Product Picture of Childhood (0-6)
Figure 19. Product Picture of Juvenile (7-17)
Figure 20. Product Picture of Youth (18-40)
Figure 21. Product Picture of Middle Aged (41-60)
Figure 22. Product Picture of Elderly (Above 60)
Figure 23. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2019-2030) & (USD/Unit)
Figure 28. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (%), (2019-2030)
Figure 40. United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 46. China Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 48. China Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 58. India Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 60. India Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 61. Anti-Obesity Drugs (Anti-obesity Medication) Industrial Chain
Figure 62. Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Anti-Obesity Drugs (Anti-obesity Medication) Market Trends
Table 2. Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers & Opportunity
Table 3. Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
Table 4. Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
Table 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2019-2024)
Table 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Anti-Obesity Drugs (Anti-obesity Medication) Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Anti-Obesity Drugs (Anti-obesity Medication)
Table 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (2019-2024) & (%)
Table 44. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Region (2025-2030) & (%)
Table 45. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (2019-2024) & (%)
Table 49. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Region (2025-2030) & (%)
Table 50. Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume, (2025-2030) & (K Units)
Table 57. Zafgan Company Information
Table 58. Zafgan Introduction and Business Overview
Table 59. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 61. Zafgan Recent Development
Table 62. Vivus Company Information
Table 63. Vivus Introduction and Business Overview
Table 64. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 66. Vivus Recent Development
Table 67. Shionogi Company Information
Table 68. Shionogi Introduction and Business Overview
Table 69. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 71. Shionogi Recent Development
Table 72. Sanofi Company Information
Table 73. Sanofi Introduction and Business Overview
Table 74. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 76. Sanofi Recent Development
Table 77. Rhythm Pharmaceuticals Company Information
Table 78. Rhythm Pharmaceuticals Introduction and Business Overview
Table 79. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 81. Rhythm Pharmaceuticals Recent Development
Table 82. Pfizer Company Information
Table 83. Pfizer Introduction and Business Overview
Table 84. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 86. Pfizer Recent Development
Table 87. Orexigen Therapeutics Company Information
Table 88. Orexigen Therapeutics Introduction and Business Overview
Table 89. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 91. Orexigen Therapeutics Recent Development
Table 92. Novo Nordisk Company Information
Table 93. Novo Nordisk Introduction and Business Overview
Table 94. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 96. Novo Nordisk Recent Development
Table 97. Norgine Company Information
Table 98. Norgine Introduction and Business Overview
Table 99. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 101. Norgine Recent Development
Table 102. Nalpropion Pharmaceuticals Inc. Company Information
Table 103. Nalpropion Pharmaceuticals Inc. Introduction and Business Overview
Table 104. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 106. Nalpropion Pharmaceuticals Inc. Recent Development
Table 107. Merck Company Information
Table 108. Merck Introduction and Business Overview
Table 109. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 111. Merck Recent Development
Table 112. GlaxoSmithKline Company Information
Table 113. GlaxoSmithKline Introduction and Business Overview
Table 114. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 116. GlaxoSmithKline Recent Development
Table 117. F.Hoffmann-La Roche Company Information
Table 118. F.Hoffmann-La Roche Introduction and Business Overview
Table 119. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 121. F.Hoffmann-La Roche Recent Development
Table 122. Eisai Company Information
Table 123. Eisai Introduction and Business Overview
Table 124. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 126. Eisai Recent Development
Table 127. Boehringer Ingelheim Company Information
Table 128. Boehringer Ingelheim Introduction and Business Overview
Table 129. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 131. Boehringer Ingelheim Recent Development
Table 132. Bayer AG Company Information
Table 133. Bayer AG Introduction and Business Overview
Table 134. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 136. Bayer AG Recent Development
Table 137. AstraZeneca Company Information
Table 138. AstraZeneca Introduction and Business Overview
Table 139. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 141. AstraZeneca Recent Development
Table 142. Arena Pharmaceuticals Company Information
Table 143. Arena Pharmaceuticals Introduction and Business Overview
Table 144. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 146. Arena Pharmaceuticals Recent Development
Table 147. Amylin Company Information
Table 148. Amylin Introduction and Business Overview
Table 149. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 150. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 151. Amylin Recent Development
Table 152. Alizyme Company Information
Table 153. Alizyme Introduction and Business Overview
Table 154. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 155. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 156. Alizyme Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Anti-Obesity Drugs (Anti-obesity Medication) Downstream Customers
Table 160. Anti-Obesity Drugs (Anti-obesity Medication) Distributors List
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Obesity Drugs (Anti-obesity Medication) Product Picture
Figure 2. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (2019-2030) & (K Units)
Figure 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Price (2019-2030) & (USD/Unit)
Figure 6. Anti-Obesity Drugs (Anti-obesity Medication) Report Years Considered
Figure 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Anti-Obesity Drugs (Anti-obesity Medication) Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2023
Figure 10. Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Prescription Drugs Picture
Figure 12. OTC Drugs Picture
Figure 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2019-2030) & (USD/Unit)
Figure 18. Product Picture of Childhood (0-6)
Figure 19. Product Picture of Juvenile (7-17)
Figure 20. Product Picture of Youth (18-40)
Figure 21. Product Picture of Middle Aged (41-60)
Figure 22. Product Picture of Elderly (Above 60)
Figure 23. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2019-2030) & (USD/Unit)
Figure 28. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (%), (2019-2030)
Figure 40. United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 46. China Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 48. China Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 58. India Anti-Obesity Drugs (Anti-obesity Medication) Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Type (%), 2023 VS 2030
Figure 60. India Anti-Obesity Drugs (Anti-obesity Medication) Sales Value by Application (%), 2023 VS 2030
Figure 61. Anti-Obesity Drugs (Anti-obesity Medication) Industrial Chain
Figure 62. Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232